Umbhali: Gregory Harris
Umhla Wokudalwa: 10 Utshazimpuzi 2021
Hlaziya Umhla: 1 Utshazimpuzi 2025
Anonim
Organic Guaraná in Brazil: Indigenous peoples show the way | Global Ideas
Ividiyo: Organic Guaraná in Brazil: Indigenous peoples show the way | Global Ideas

Umxholo

IGuarana sisityalo. Ibizwa ngokuba sisizwe samaGuarani eAmazon, esisebenzise imbewu yayo ukwenza isiselo. Namhlanje, imbewu yeguarana isasetyenziswa njengeyeza.

Abantu bathatha i-guarana ngomlomo ukutyeba kakhulu, ukusebenza kweembaleki, ukusebenza kwengqondo, ukonyusa amandla, njenge-aphrodisiac, kunye nezinye iimeko ezininzi, kodwa abukho ubungqina benzululwazi obuxhasa ezi zinto zisetyenziswayo. I-Guarana nayo inokungakhuselekanga xa ithathwa ixesha elide ngesixa esikhulu.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IGUARANA zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Ixhala. Uphando lwakwangoko lubonisa ukuba ukuthatha imveliso ene-hawthorn, i-horehound emnyama, i-passionflower, i-valerian, i-cola nut, kunye ne-guarana kunokunciphisa uxinzelelo kwabanye abantu. Akucaci ukuba i-guarana iyodwa iyinzuzo.
  • Ukungabikho komdla kubantu abanomdlavuza. Uphando lwakwangoko lubonisa ukuba ukuthatha i-guarana kukhupha kancinci kuphucula ukutya kwaye kuthintele ukwehla kobunzima kubantu abanomhlaza abaphulukene nomdla wokutya kwaye baphulukana nobunzima. Kodwa isibonelelo sincinci kakhulu.
  • Ukudinwa kwabantu abaphathwe ngamachiza omhlaza. Olunye uphando lubonisa ukuba ukuthatha i-guarana kunokunciphisa ukudinwa kwabanye abantu abafumana unyango lwe-chemotherapy. Kodwa iziphumo ezingqubanayo zikhona.
  • Ukuphucula inkumbulo kunye nezakhono zokucinga (umsebenzi wokuqonda). Uphando lwakwangoko kubantu abasempilweni lubonisa ukuba ukuthatha idosi enye yokukhupha i-guarana kunokuphucula isantya sokucinga kunye neminye imiba yememori. Nangona kunjalo, olunye uphando lubonisa ukuba ukuthatha i-guarana akuphuculi ukusebenza kwengqondo kubantu abadala okanye kubantu abadala.
  • Ukusebenza kwezemidlalo. Uphando lubonisa ukuba ukuthatha idosi enye yemveliso equkethe i-guarana, iivithamini B, ivithamin C, kunye neeminerals kuphucula ukunyamezeleka kokuzilolonga kwiimbaleki eziqeqeshiweyo ngesixa esincinci kakhulu. Akucaci ukuba i-guarana iyodwa iyinzuzo.
  • Ukutyeba kakhulu. Ukuthatha i-guarana kunye neqabane kunye nedamiana kubonakala ngathi kukwandisa ukunciphisa umzimba. Kukho ubungqina obukhulayo bokuba ukuthatha indibaniselwano yemveliso ethile equlathe i-guarana, ephedra, kunye ne-17 ezinye iivithamini, iiminerali, kunye nezongezo zinceda ukunciphisa ubunzima malunga ne-2.7 kg ngaphezulu kweeveki ezisi-8 xa isetyenziswa kukutya okunamafutha asezantsi kunye nokuzilolonga. Akucaci ukuba i-guarana iyodwa iyinzuzo.
  • Imvakalelo yempilo-ntle. Uphando lwakwangoko lubonisa ukuba ukuthatha i-guarana akuyiphuculi imvakalelo yokuba sempilweni kubantu abasempilweni.
  • Isigulo esibi esibangelwa kukuvezwa yimitha. Uphando lubonisa ukuba ukuthatha i-guarana akuphuculi zimpawu zokudakumba okanye ukudinwa kubantu abanyangwa yimitha.
  • Ukusebenza kwezemidlalo.
  • Ukudinwa okungapheliyo (i-CFS).
  • Urhudo.
  • Ukungasebenzi kakuhle kwe-Erectile (ED).
  • Ukudinwa.
  • Ifiva.
  • Ukugcina ulwelo.
  • Intloko ebuhlungu.
  • Isifo sentliziyo.
  • Ukonyusa umnqweno wesondo kubantu abasempilweni.
  • Uxinzelelo lwegazi oluphantsi.
  • Isifo seengcongconi.
  • Ukuxhuzula kokuya exesheni (idysmenorrhea).
  • Isifo samathambo (RA).
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-guarana kwezi zinto zisetyenziswayo.

IGuarana iqulethe icaffeine. I-caffeine isebenza ngokukhuthaza inkqubo ye-nervous system (CNS), intliziyo kunye nezihlunu. IGuarana iqulethe i-theophylline kunye ne-theobromine, eziyimichiza efana ne-caffeine.

Xa kuthathwa ngomlomo: UGuarana ngu NGOKUKHUSELEKILEYO kubantu abaninzi abadala xa bethathwa ngezixa ezifumaneka ngokutya rhoqo. Xa uthathwa ngomlomo kwixabiso lokunyanga ixesha elifutshane, i-guarana UKHUSELEKO OLUNOKWENZEKA.

Xa uthathwe ngomlomo kwiidosi eziphezulu ixesha elide, igararana OKUNGENZEKA UKHUSELEKILE. IGuarana iqulethe icaffeine. Iidosi eziqulathe ngaphezulu kwe-400 mg ye-caffeine mihla le inxulunyaniswe neziphumo ebezingalindelekanga. Iziphumo zixhomekeke kwidosi. Ngeedosi eziqhelekileyo, icaffeine eseguarana inokubangela ukuphuthelwa, ukoyika nokungazinzi, ukucaphuka esiswini, isicaphucaphu, ukugabha, ukunyuka kwentliziyo kunye noxinzelelo lwegazi, ukuphefumla ngokukhawuleza, ukungcangcazela, isifo sokuqaqanjelwa sisisu, nezinye izinto ebezingalindelekanga. Iidosi ezinkulu ze-guarana zinokubangela intloko ebuhlungu, ixhala, ukuphazamiseka, ukukhala ezindlebeni, iintlungu xa uchama, isisu esibuhlungu, kunye nokubetha kwentliziyo okungaqhelekanga. Abantu abathatha i-guarana rhoqo banokufumana iimpawu zokurhoxa i-caffeine ukuba bayayinciphisa idosi yabo yesiqhelo.

Xa uthathwe ngomlomo okanye utofelwe ngeedosi eziphezulu kakhulu, i-guarana NGOKUFANELEKILEYO kwaye iyabulala, ngenxa yomxholo wayo wecaffeine. Umthamo obulalayo we-caffeine uqikelelwa kwi-10-14 gram. Ityhefu enzulu inokubakho ngeedosi ezisezantsi, kuxhomekeke kubuntununtunu be-caffeine okanye indlela yokuziphatha yokutshaya, ubudala, kunye nokusetyenziswa kwangaphambili kwecaffeine.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: UGuarana ngu UKHUSELEKO OLUNOKWENZEKA yabasetyhini abakhulelweyo nabancancisayo xa bethathwa ngezixa ezifumaneka ngokutya rhoqo. Ukuba ukhulelwe okanye uncancisa, i-guarana kufuneka ithathwe ngononophelo ngenxa yomxholo wecaffeine. Imali encinci mhlawumbi ayinabungozi. Nangona kunjalo, ukuthatha i-guarana ngeedosi eziphezulu ngomlomo OKUNGENZEKA UKHUSELEKILE. Ukutya ngaphezulu kwe-300 mg ye-caffeine mihla le kunxulunyaniswe nomngcipheko okhulayo wokuphuma kwesisu kunye nezinye iziphumo ezibi.

Kwabasetyhini abanyisayo, icaffeine idlulela kubisi lwebele kwaye inokuchaphazela usana olunyisayo. Oomama abangabahlengikazi kufuneka bajonge ngononophelo ukutya kwe-caffeine ukuze kuqinisekiswe ukuba ikwicala eliphantsi. Ukutya kakhulu i-caffeine ngoomama abangabongikazi kunokubangela iingxaki zokulala, ukucaphuka, kunye nokwanda kwamathumbu kwiintsana ezincancisayo.

Ixhala: I-caffeine kwi-guarana inokwenza iimvakalelo zoxinzelelo zibe mandundu.

Iingxaki zokopha: Kukho ubungqina obucebisa ukuba i-caffeine ese-guarana inokwenza iingxaki zokopha zibe mbi, nangona oku kungakhange kuxelwe ebantwini. Ukuba unengxaki yokopha, jonga kumboneleli wezempilo ngaphambi kokuba uqalise i-guarana.

Seswekile: Olunye uphando lubonisa ukuba i-caffeine e-guarana inokuchaphazela indlela abantu abanesifo seswekile kwinkqubo yeswekile (iswekile) kwaye inokuba nzima kulawulo lweswekile yegazi. Kukho nolunye uphando olunomdla olucebisa ukuba icaffeine inokunyusa iimpawu zesilumkiso seswekile esezantsi kwizigulana ezinesifo seswekile sokuqala. Olunye uphononongo lubonisa ukuba iimpawu zeswekile esezantsi yegazi ziba namandla ngakumbi xa ziqala ngokungabikho kwe-caffeine, kodwa njengoko iswekile esezantsi yegazi iqhubeka, iimpawu zikhulu ngecaffeine. Oku kunokunyusa amandla ezigulana ezineswekile ukuba zibone kwaye zinyange iswekile esezantsi yegazi. Nangona kunjalo, icala eliphantsi kukuba icaffeine inokunyusa inani leziqwengana zeswekile esezantsi. Ukuba unesifo seswekile, thetha nomboneleli wakho wezempilo ngaphambi kokuba uqale i-guarana.

Urhudo. IGuarana iqulethe icaffeine. I-caffeine ese-guarana, ngakumbi xa isiwe kakhulu, inokulwenza luluhle kakhulu urhudo.

Ukuxhuzula. IGuarana iqulethe icaffeine. I-caffeine e-guarana inokunyusa umngcipheko wokuxhuzula kunye nokunciphisa izibonelelo zamayeza amaninzi asetyenziselwa ukulawula ukuxhuzula. Ukuba uxhuzula, thetha nomboneleli wakho wezempilo ngaphambi kokuba usebenzise i-guarana.

Isifo sengqondo sesifo esibuhlungu (IBS): IGuarana iqulethe icaffeine. I-caffeine e-guarana, ngakumbi xa ithathwa ngesixa esikhulu, inokulwenza luluhle kakhulu urhudo kwaye isenokulwenza lubi ngakumbi urhudo abanye abantu abanalo nge-IBS.

Isifo sentliziyo: I-caffeine e-guarana inokubangela ukubetha kwentliziyo ngendlela engaqhelekanga kubantu abathile. Sebenzisa ngononophelo.

Igazi elonyukayoUkuthatha i-guarana kunokunyusa uxinzelelo lwegazi, kubantu abanexinzelelo lwegazi ngenxa yomxholo wecaffeine. Nangona kunjalo, oku kunokuba kuncinci kubantu abasela ikofu rhoqo okanye basebenzise icaffeine rhoqo.

Iglaucoma: I-caffeine kwi-guarana yonyusa uxinzelelo ngaphakathi kwamehlo. Ukonyuka kwenzeka ngaphakathi kwemizuzu engama-30 kwaye kuhlala ubuncinci imizuzu engama-90 emva kokusela iziselo ezine-caffeine.

Iingxaki zolawulo lwesinyi (Incontinence): IGuarana iqulethe icaffeine. I-caffeine ese-guarana inokunciphisa ulawulo lwesinyi, ngakumbi kubafazi abadala. Ukuba ufuna ukuchama rhoqo ngokungxamiseka okukhulu, sebenzisa i-guarana ngononophelo.

Unyango: I-caffeine ese-guarana inokukhupha i-calcium emzimbeni ngezintso. Ukulahleka kwecalcium kunokunciphisa amathambo. Ukuba une-osteoporosis, musa ukusebenzisa ngaphezu kwe-300 mg ye-caffeine ngosuku. Ukuthatha izongezo zecalcium kunokunceda ukubuyisela nayiphi na ikhalsiyam elahlekileyo. Ukuba uphilile ngokubanzi kwaye ufumana ikhalsiyam eyaneleyo ekutyeni okanye kwizongezo zakho, ukuthatha ukuya kwi-400 mg ye-caffeine ngosuku akubonakali kwandisa umngcipheko wokufumana i-osteoporosis.

Ischizophrenia: IGuarana iqulethe icaffeine. I-caffeine e-guarana inokwenza ezinye iimpawu zesifo sengqondo ukuba sibengcono. Ukuba une-schizophrenia, sebenzisa i-guarana ngononophelo.

Mkhulu
Sukuyithatha le indibaniselwano.
IiAmphetamines
Iziyobisi ezikhuthazayo ezinje ngeamphetamines zikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine ese-guarana nayo inokukhawulezisa inkqubo yeemvakalelo. Ukuthatha i-guarana kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinzulu kubandakanya ukubetha kwentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye necaffeine.
Cocaine
Iziyobisi ezikhuthazayo ezinje ngecocaine ikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine ese-guarana nayo inokukhawulezisa inkqubo yeemvakalelo. Ukuthatha i-guarana kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinzulu kubandakanya ukubetha kwentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye necaffeine.
Ephedrine
Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. I-Caffeine (equlethwe kwi-guarana) kunye ne-ephedrine zombini iziyobisi ezikhuthazayo. Ukuthatha i-guarana kunye ne-ephedrine kunokubangela ukhuthazo kakhulu kwaye ngamanye amaxesha kube neziphumo ebezingalindelekanga ezinzulu kunye neengxaki zentliziyo. Musa ukuthatha iimveliso ezine-caffeine kunye ne-ephedrine ngaxeshanye.
Iphakathi
Lumka ngale nhlanganisela.
Adenosine (Adenocard)
IGuarana iqulethe icaffeine. I-caffeine e-guarana inokuthintela ifuthe le-adenosine (Adenocard). I-Adenosine (Adenocard) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Yeka ukusebenzisa i-guarana okanye ezinye iimveliso ezinecaffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo lwentliziyo.
ICarbamazepine (iTegretol)
ICarbamazepine (Tegretol) isetyenziselwa ukunyanga ukubanjwa. I-caffeine kwi-guarana inokunciphisa iziphumo ze-carbamazepine (Tegretol) okanye yonyuse indlela umntu anokuthi abambe ngayo. Kwithiyori, ukuthatha i-guarana kunye ne-carbamazepine (Tegretol) kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa kwabanye abantu.
ICimetidine (iTagamet)
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Cimetidine (iTagamet) inokunciphisa ukuba umzimba wakho uyaphula ngokukhawuleza njani icaffeine. Ukuthatha i-cimetidine (Tagamet) kunye ne-guarana kunokunyusa amathuba okuba neziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezileyo, kunye nabanye.
IClozapine (iClozaril)
Umzimba uyaphula i-clozapine (Clozaril) ukuze uyilahle. I-caffeine ese-guarana ibonakala ngathi iyacutha ukuba umzimba uphula njani i-clozapine ngokukhawuleza (Clozaril). Ukuthatha i-guarana kunye ne-clozapine (Clozaril) kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-clozapine (Clozaril).
IDipyridamole (iPantantine)
IGuarana iqulethe icaffeine. I-caffeine kwi-guarana inokuthintela iziphumo ze-dipyridamole (Persantine). IDipyridamole (Persantine) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Yeka ukusebenzisa i-guarana okanye ezinye iimveliso ezinecaffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo lwentliziyo.
Idisulfiram (iAntabuse)
Umzimba uyayaphula icaffeine ukuze uyilahle. I-Disulfiram (i-Antabuse) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukuthatha i-guarana (equlethe i-caffeine) kunye ne-disulfiram (i-Antabuse) kunokunyusa iziphumo kunye neziphumo zecaffeine kubandakanya i-jitteriness, hyperactivity, irritability, kunye nabanye.
Estrogens
Umzimba uyaphula i-caffeine e-guarana ukuyilahla. I-Estrogens inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha i-guarana kunye ne-estrogens kunokubangela ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezileyo, kunye nezinye iziphumo ebezingalindelekanga. Ukuba uthatha ii-estrogens, nciphisa umlinganiselo wakho wecaffeine.

Ezinye iipilisi ze-estrogen zibandakanya i-equine estrogens (Premarin), i-ethinyl estradiol, i-estradiol kunye nezinye.
I-Ethosuximide
I-Ethnosuximide isetyenziselwa ukulawula iintlobo ezithile zokubanjwa. I-caffeine kwi-guarana inokunciphisa iziphumo ze-ethnosuximide okanye yonyuse indlela umntu anokuchaphazeleka ngayo ekuthinjweni. Kwithiyori, ukuthatha i-guarana kunye ne-ethnosuximide kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa.
Felbamate
I-Felbamate isetyenziselwa ukulawula iintlobo ezithile zokubanjwa. I-caffeine kwi-guarana inokunciphisa iziphumo ze-felbamate okanye yonyuse indlela umntu anokuthi abambe ngayo. Kwithiyori, ukuthatha i-guarana kunye ne-felbamate kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa.
IFlutamide (i-Eulexin)
Umzimba uqhekeza i-flutamide (i-Eulexin) ukuze uyilahle. I-caffeine kwi-guarana inokunciphisa ngokukhawuleza ukuba umzimba uphule njani i-flutamide (i-Eulexin). Kwithiyori, ukuthatha i-guarana kunye ne-flutamide (i-Eulexin) kunokubangela i-flutamide (i-Eulexin) eninzi emzimbeni kunye nokwandisa umngcipheko weziphumo ebezingalindelekanga.
IFluvoxamine (iLuvox)
Umzimba uyaphula i-caffeine e-guarana ukuyilahla. I-Fluvoxamine (Luvox) inganciphisa ukuba umzimba uphula njani ngokukhawuleza icaffeine. Ukuthatha i-guarana kunye ne-fluvoxamine (i-Luvox) kunokubangela i-caffeine eninzi emzimbeni, kwaye kwandise iziphumo kunye neempembelelo ze-caffeine.
ILithium
Umzimba wakho ngokwendalo ulahla i-lithium. I-caffeine ese-guarana inokunyusa ukuba umzimba wakho ulahla njani ngokukhawuleza nge-lithium. Ukuba uthatha iimveliso eziqukethe i-caffeine kwaye uthatha i-lithium, yeka ukuthatha iimveliso ze-caffeine kancinci. Ukuyeka i-caffeine ngokukhawuleza kunokunyusa iziphumo ebezingalindelekanga ze-lithium.
Amayeza esifuba (i-Beta-adrenergic agonists)
IGuarana iqulethe icaffeine. I-caffeine inokuvuselela intliziyo. Amanye amayeza esifuba anokukhuthaza nentliziyo. Ukuthatha i-caffeine kunye namanye amayeza e-asthma kunokubangela ukuvuselela kakhulu kwaye kubangele iingxaki zentliziyo.

Amanye amayeza e-asthma afaka i-albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), kunye ne-isoproterenol (Isuprel).
Amayeza oxinzelelo (MAOIs)
IGuarana iqulethe icaffeine. I-caffeine inokuvuselela umzimba. Amanye amayeza asetyenziselwa uxinzelelo anokuvuselela umzimba. Ukuthatha i-guarana ngala mayeza asetyenziselwa uxinzelelo kunokubangela iziphumo ebezingalindelekanga ezinzulu kubandakanya ukubetha kwentliziyo okukhawulezayo, uxinzelelo lwegazi oluphezulu, uvalo kunye nabanye.

Olunye lala mayeza asetyenziselwa uxinzelelo lubandakanya i-phenelzine (Nardil), tranylcypromine (Parnate), kunye nezinye.
Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)
IGuarana iqulethe icaffeine. I-caffeine inokunciphisa ukucinywa kwegazi. Ukuthatha i-guarana kunye namayeza acothisa ukucola kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.
Inikotini
Iziyobisi ezikhuthazayo ezifana nenicotine ikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine ese-guarana nayo inokukhawulezisa inkqubo yeemvakalelo. Ukuthatha i-guarana kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinzulu kubandakanya ukubetha kwentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye necaffeine.
IPentobarbital (iNembutal)
Iziphumo ezikhuthazayo zecaffeine ese-guarana zinokuthintela ukuvelisa iziphumo zokulala kwepentobarbital.
IPhenobarbital
I-Phenobarbital isetyenziselwa ukulawula ezinye iintlobo zokubanjwa. I-Caffeine, equlethwe kwi-guarana, inokunciphisa iziphumo ze-phenobarbital okanye inyuse indlela umntu anokuchaphazeleka ngayo ekuthinjweni. Kwithiyori, ukuthatha i-guarana kunye ne-phenobarbital kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa.
IPhenylpropanolamine
I-caffeine kwi-guarana inokuvuselela umzimba. I-Phenylpropanolamine inokuvuselela umzimba. Ukuthatha i-guarana kunye ne-phenylpropanolamine kunokubangela ukukhuthaza kakhulu kunye nokunyusa ukubetha kwentliziyo, uxinzelelo lwegazi kunye nokubangela uloyiko.
IPhenytoin
IPhenytoin isetyenziselwa ukulawula ezinye iintlobo zokubanjwa. I-caffeine kwi-guarana inokunciphisa iziphumo ze-phenytoin okanye inyuse indlela umntu anokuthi abambe ngayo. Kwithiyori, ukuthatha i-guarana kunye ne-phenytoin kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa.
Riluzole (Rilutek)
Umzimba uqhekeza i-riluzole (iRilutek) ukuyikhupha. Ukuthatha i-guarana kunokunciphisa ukukhawuleza komzimba ukuphula i-riluzole (Rilutek) kunye nokwandisa iziphumo kunye neziphumo ebezingalindelekanga ze-riluzole.
Iziyobisi ezikhuthazayo
Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza avuselelayo anokukwenza uzive ujitter kwaye ukhawulezise ukubetha kwentliziyo yakho. IGuarana iqulethe icaffeine, nayo ekhawulezisa inkqubo yeemvakalelo. Ukuthatha i-guarana kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinzulu kubandakanya ukubetha kwentliziyo kunye noxinzelelo lwegazi. Kuphephe ukusebenzisa iziyobisi ezikhuthazayo kunye neguarana.

Ezinye iziyobisi ezikhuthazayo zibandakanya inikotini, icocaine, iiamine zesyathomometic, kunye neamphetamines.
Ithiophylline
IGuarana iqulethe icaffeine. I-caffeine isebenza ngokufanayo kwi-theophylline. I-caffeine inokunciphisa ngokukhawuleza ukuba umzimba ulahla njani i-theophylline. Ukuthatha i-guarana kunye ne-theophylline kunokunyusa iziphumo kunye neempembelelo ze-theophylline.
IValproate
IValproate isetyenziselwa ukulawula ezinye iintlobo zokubanjwa. I-caffeine kwi-guarana inokunciphisa iziphumo ze-valproate okanye inyuse indlela umntu anokuthi abambe ngayo. Kwithiyori, ukuthatha i-guarana nge-valproate kunokunciphisa iziphumo kunye nokunyusa umngcipheko wokubanjwa.
IVerapamil (iCanan, iCovera, iIsoptin, iVerelan)
Umzimba uyaphula i-caffeine e-guarana ukuyilahla. I-Verapamil (Calan, Covera, Isoptin, Verelan) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukuthatha i-guarana kunye ne-verapamil (Calan, Covera, Isoptin, Verelan) kunokunyusa umngcipheko weziphumo ze-caffeine kubandakanya ukonwaba, intloko ebuhlungu kunye nentliziyo eyandayo.
Iipilisi zamanzi (iziyobisi zeDiuretic)
IGuarana iqulethe icaffeine. I-caffeine inokunciphisa amanqanaba e-potassium. "Iipilisi zamanzi" zinokunciphisa amanqanaba e-potassium emzimbeni. Kwithiyori, ukuthatha i-guarana ngeepilisi zamanzi kunokubangela amanqanaba e-potassium ukuba ehle kakhulu
Ezinye "iipilisi zamanzi" ezinokuphelisa i-potassium zibandakanya i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), nezinye.
Incinci
Jonga olu dibaniso.
Utywala
Umzimba uyaphula i-caffeine e-guarana ukuyilahla. Utywala bunokunciphisa ukuba umzimba uphula ngokukhawuleza njani ikhafeyini. Ukuthatha i-guarana kunye notywala kunokubangela i-caffeine eninzi kwigazi kunye neziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu kunye nentliziyo ebetha ngamandla.
Iintsholongwane (iquinolone antibiotics)
Umzimba uqhekeza icaffeine kwi-guarana ukuze uyilahle. Amanye amachiza anokunciphisa ngokukhawuleza ukuba umzimba uyaphula icaffeine. Ukuthatha la machiza kunye ne-guarana kunokunyusa umngcipheko weziphumo ebezingalindelekanga kubandakanya ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo, kunye nezinye.

Ezinye i-antibiotics ezinciphisa ngokukhawuleza ukuba umzimba uphule i-caffeine zibandakanya i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), kunye nezinye
Iipilisi zolawulo lokuzalwa (iziyobisi zokuthintela ukukhulelwa)
Umzimba uyaphula i-caffeine e-guarana ukuyilahla. Iipilisi zolawulo lokuzalwa zinganciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Ukuthatha i-guarana kunye neepilisi zokulawula ukuzalwa kunokubangela ukothuka, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezileyo, kunye nezinye iziphumo ebezingalindelekanga.

Ezinye iipilisi zolawulo lokuzalwa zibandakanya i-ethinyl estradiol kunye ne-levonorgestrel (Triphasil), i-ethinyl estradiol kunye ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), kunye nezinye.
IFluconazole (iDiflucan)
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Fluconazole (Diflucan) inokunciphisa ngokukhawuleza ukuba umzimba uyilahla njani icaffeine Ukuthatha i-guarana kunye ne-fluconazole (Diflucan) kunokunyusa umngcipheko weziphumo ebezingalindelekanga ezifana novalo, ixhala kunye nokuqaqanjelwa sisisu.
Amayeza eswekile (iziyobisi zeAntidiabetes)
IGuarana inokunyusa iswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ngokwandisa iswekile yegazi, i-guarana inokunciphisa ukusebenza kwamayeza eswekile. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .
Amayeza anciphisa ukwehla kwamanye amayeza sisibindi (ICytochrome P450 1A2 (CYP1A2) inhibitors)
IGuarana iqulethe icaffeine. I-caffeine iyatshintshwa ize yophulwe sisibindi. Amanye amachiza anciphisa indlela isibindi esitshintsha ngayo ngokukhawuleza kwaye siwaphule amayeza athile kunye nezongezo. Ukuthatha i-guarana kunye nala machiza kunokunciphisa ukubola kwe-caffeine kunye nokunyusa amanqanaba e-caffeine.
Amanye ala mayeza achaphazela isibindi aquka i-fluvoxamine, i-mexiletine, i-clozapine, i-psoralens, i-furafylline, i-theophylline, i-idrocilamide kunye nezinye.
IMetformin
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Metformin inokunciphisa ngokukhawuleza ukuba umzimba uphula njani i-caffeine. Ukuthatha i-metformin kunye ne-guarana kunokunyusa iziphumo kunye neempembelelo zecaffeine.
Methoxsalen
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Methoxsalen inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha i-methoxsalen kunye ne-guarana kunokunyusa iziphumo kunye neempembelelo zecaffeine.
Mexiletine (Mexitil)
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Mexiletine (Mexitil) inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha i-mexiletine (Mexitil) kunye ne-guarana kunokunyusa iziphumo ze-caffeine kunye neziphumo ebezingalindelekanga ze-guarana.
Iiphenothiazines
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. Iiphenothiazines zinokunciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Ukuthatha i-phenothiazines kunye ne-guarana kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga.
I-Terbinafine (iLamisil)
Umzimba uyaphula i-caffeine (equlethwe kwi-guarana) ukuyilahla. I-Terbinafine (i-Lamisil) inganciphisa ukuba umzimba ulahla njani ikhafeyini ngokukhawuleza kwaye inyuse umngcipheko weziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu, ukubetha kwentliziyo kunye nezinye iziphumo.
Itiagbine
I-Tiagabine isetyenziselwa ukulawula ezinye iintlobo zokubanjwa. I-caffeine kwi-guarana ibonakala ngathi ayinampembelelo kwiziphumo ze-tiagabine. Nangona kunjalo, ukusetyenziswa kwecaffeine yexesha elide kunokunyusa amanqanaba egazi le-tiagabine. Kwithiyori, ukusetyenziswa kwexesha elide kwe-guarana kunokuba nefuthe elifanayo.
ITiclopidine (iTiclid)
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Ticlopidine (Ticlid) inokunciphisa ukuba umzimba ukhawuleza ulahle njani icaffeine. Kwithiyori, ukuthatha i-guarana kunye ne-ticlopidine (Ticlid) kunokunyusa umngcipheko weziphumo ze-caffeine.
Ikrakra iorenji
IGuarana iqulethe icaffeine. Ukuthatha iorenji ekrakra kunye nemifuno ene-caffeine, efana ne-guarana, inokunyusa uxinzelelo lwegazi kunye nokubetha kwentliziyo kubantu abangenalo uxinzelelo lwegazi oluqhelekileyo. Oku kunokunyusa ithuba lokuphuhlisa iingxaki ngentliziyo kunye nemithambo yegazi.
Imifuno eneCaffeine kunye nezongezo
IGuarana iqulethe icaffeine. Ukuyithatha ngamanye amayeza kunye nezongezo eziqulathe icaffeine kunokunyusa zombini iziphumo eziyingozi neziluncedo zecaffeine. Ezinye iimveliso zendalo eziqukethe i-caffeine zibandakanya ikofu, iti emnyama, iti eluhlaza, iti ye-oolong, iti ye-erh, iqabane kunye necola.
Ikhalsiyam
Ukutya okuphezulu kwe-caffeine kukutya, iziselo, kunye nemifuno kubandakanya i-guarana yonyusa ukuphuma kwe-calcium yomchamo.
Yila
Kukho inkxalabo yokuba ukudibanisa icaffeine, i-ephedra, kunye ne-creatine kunokunyusa umngcipheko weziphumo ebezingalindelekanga ezibi. Kukho ingxelo yestroke kwimbaleki ethathe iigrama ezi-6 ze-creatine monohydrate, i-400-600 mg ye-caffeine, i-40-60 mg ye-ephedra, kunye nezinye izongezo zemihla ngemihla iiveki ezi-6. I-caffeine inokunciphisa iziphumo zokudala ezinokubakho kwimidlalo.
Danshen
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Danshen inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Sebenzisa i-danshen nge-guarana kunokunyusa amanqanaba e-caffeine.
Echinachea
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Echinacea inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Sebenzisa i-echinacea ene-guarana kunokunyusa amanqanaba e-caffeine.
Ephedra (Ma huang)
Ephedra yinto evuselelayo. IGuarana iyakhuthaza, ngenxa yokuba inomxholo wecaffeine. Sebenzisa i-ephedra kunye ne-guarana kunokubangela ukukhuthazeka kakhulu emzimbeni. Ingxelo enye engashicilelwanga inxulumana nobukrakra, uxinzelelo lwegazi oluphezulu, ukuxhuzula, ukulahleka okwethutyana kwengqondo, kunye nokulaliswa esibhedlele kufuna inkxaso yobomi ngokusetyenziswa kwendibaniselwano ye-ephedra kunye ne-guarana (caffeine). Musa ukuthatha i-guarana nge-ephedra okanye ezinye izinto ezikhuthazayo.
Iherbs kunye nezongezo ezicothisa ukucoca igazi (iAnticoagulant / Antiplatelet herbs kunye nezongezelelo
UGuarana ubonakala ngathi uyakwazi ukucotha ukujiya kwegazi. Ukuyisebenzisa kunye namanye amayeza kunye nokuncedisa okucothisa ukucoca igazi kunokunyusa umngcipheko wokopha kwabanye abantu. Amanye ala mayeza abandakanya i-angelica, i-clove, i-danshen, igalikhi, ijinja, iginkgo kunye nePanax ginseng.
Kudzu
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. UKudzu unokunciphisa ukuba umzimba uyaphula ngokukhawuleza njani icaffeine. Sebenzisa i-kudzu kunye ne-guarana kunokunyusa amanqanaba e-caffeine.
Magnesium
Ukutya okuphezulu kwe-caffeine kukutya, iziselo, kunye nemifuno kubandakanya i-guarana yonyusa ukuphuma kwe-magnesium.
IMelatonin
IGuarana iqulethe icaffeine. Ukuthatha i-caffeine kunye ne-melatonin kunokunyusa amanqanaba e-melatonin. Kwithiyori, ukuthatha i-guarana kunye ne-melatonin kunokunyusa amanqanaba e-melatonin.
I-clover ebomvu
IGuarana iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. Ukuthatha i-clover ebomvu kunokunciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Kwithiyori, ukuthatha i-clover ebomvu nge-guarana kunokunyusa amanqanaba e-caffeine.
Akukho kunxibelelana kwaziwayo nokutya.
Idosi efanelekileyo yeguarana ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi ze-guarana. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Cocoa yaseBrazil, iCacao Brésilien, iGuarana Seed Extract, iGuaranine, iPaullinia cupana, iPaullinia sorbilis, Zoom.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. Nguyen S, Rajfer J, Shaheen M. Ukhuseleko kunye nokusebenza kwe-Revactin yemihla ngemihla kumadoda ane-erectile dysfunction: isifundo somqhubi weenyanga ezi-3. Guqula u-Androl Urol. 2018; 7: 266-73. Jonga i-abstract.
  2. Silva CP, Sampaio GR, Freitas RAMS, Torres EAFS. Iipolyphenol ezivela kwi-guaraná emva kwe-vitro digestion: Uvavanyo lokufumaneka kunye nokuthintela umsebenzi we-enzayimisi ye-carbohydrate-hydrolyzing. Ukutya Chem 2018; 267: 405-9. ikhonkco: 10.1016 / j.foodchem.2017.08.078. Jonga i-abstract.
  3. Cwangcisa i-CVM, iRibas de Alcântara BB, iSchoueri JHM, et al. Ukucoca i-Paullinia cupana (PC-18) yokuhlanjululwa eyomileyo ye-chemotherapy-fatigue: iziphumo zolingo lweeklinikhi ezimbini ezingaboniyo. J Ukutya Suppl 2018; 15: 673-83. ikhonkco: 10.1080 / 19390211.2017.1384781. Jonga i-abstract.
  4. Wikoff D, Welsh BT, Henderson R, et al. Ukuphononongwa ngokuchanekileyo kweziphumo ezinokubakho zokusetyenziswa kwe-caffeine kubantu abadala abasempilweni, abasetyhini abakhulelweyo, abakwishumi elivisayo kunye nabantwana. Ukutya iChem Toxicol 2017; 109: 585-648. Jonga i-abstract.
  5. UCiszowski K, uBiedron W, uGomólka E. I-caffeine ityhefu ebonakalayo ekhokelela kwi-atrial fibrillation emva kwe-guarana yokukhupha i-overdose. Przegl Lek. Ngo-2014; 71: 495-8. Jonga i-abstract.
  6. UVeasey RC, uHaskell-Ramsay CF, uKennedy DO, uWishart K, uMaggini S, uFuchs CJ, uStevenson EJ. Iziphumo zokuNcediswa ngeVitamin kunye neMamineral Complex kunye neGuaraná Phambi kokuzilolonga ngokuzilolonga kwi-After, Exertion, Performance Cognitive, kunye ne-Substrate Metabolism: Ityala elilawulwa ngokungahleliwe. Izondlo. Ngo-2015 ngoJulayi 27; 7: 6109-27. Jonga i-abstract.
  7. I-Silvestrini GI, i-Marino F, i-Cosentino M. Iziphumo zemveliso yorhwebo equkethe i-guaraná kwintlalontle yengqondo, unxunguphalo kunye nemood: isifundo esingalawulwa sinye, esilawulwa yi-placebo kwizifundo ezisempilweni. Iziphumo zika-J Negat Biomed. Ngo-2013 ngoMeyi 25; 12: 9. Jonga i-abstract.
  8. Scholey A, Bauer I, Neale C, Savage K, Camfield D, White D, Maggini S, Pipingas A, Stough C, Hughes M. Iziphumo ezibi zamalungiselelo eemaminerali ezahlukeneyo kunye nangaphandle kweGuaraná kwimood, ukusebenza kwengqondo kunye nokusebenza kwengqondo okusebenzayo. . Izondlo. Ngo-2013 Sep 13; 5: 3589-604. Jonga i-abstract.
  9. Iipomportes L, i-Davranche K, i-Brisswalter I, i-Hays A, i-Brisswalter J.Ukuhluka kwenqanaba lentliziyo kunye nokusebenza kwengqondo kulandela ukongezwa kweevithamini kunye nezimbiwa kunye ne-guarana eyongezelelweyo (Paullinia cupana). Izondlo. Ngo-2014 uDisemba 31; 7: 196-208. Jonga i-abstract.
  10. Palma CG, Lera AT, Lerner T, de Oliveira MM, de Borta TM, Barbosa RP, Brito GM, Guazzelli CA, Cruz FJ, del Giglio A.Guarana (Paullinia cupana) Iphucula i-Anorexia kwizigulana ezinomhlaza ophambili. J Ukutya ukutya. Ngo-2016; 13: 221-31. Jonga i-abstract.
  11. UMoustakas D, uMezzio M, uRodriguez BR, uConstable MA, uMulligan ME, uVoura EB. IGuarana ibonelela ngokunyusa okongezelelweyo kwi-caffeine yodwa kwimodeli yezicwangciso. Inye. 2015 ngoMvulo 16; 10: e0123310. Jonga i-abstract.
  12. UKennedy DO, uHaskell CF, uRobertson B, uRay J, uBrewster-Maund C, uLuedemann J, uMaggini S, uRuf M, uZangara A, uScholey AB. Ukuphuculwa kokusebenza kwengqondo kunye nokudinwa kwengqondo kulandela ukongezwa kweevithamini kunye nezimbiwa kunye neguaraná (Paullinia cupana). Ukutya. I-2008 Mar-Meyi; 50 (2-3): 506-13. Jonga i-abstract.
  13. UHaskell CF, uKennedy DO, uWesnes KA, uMilne AL, uScholey AB. Uvavanyo oluyimfama kabini, olulawulwa yi-placebo, uvavanyo oluninzi lweedosi zokuziphatha okugwenxa kwe-guaraná ebantwini. J Psychopharmacol. Ngo-2007 uJan; 21: 65-70. Jonga i-abstract.
  14. del Giglio AB, Cubero Dde I, Lerner TG, Guariento RT, de Azevedo RG, Paiva H, Goldman C, Carelli B, Cruz FM, Schindler F, Pianowski L, de Matos LL, del Giglio A. Ukucoca isicatshulwa esomileyo se Paullinia cupana (guaraná) (PC-18) yokudinwa okunxulumene nekhemotherapy kwizigulana ezinamathumba aqinileyo: isifundo sokuyeka kwangoko. J Ukutya ukutya. NgoDisemba wama-2013; 10: 325-34. Jonga i-abstract.
  15. de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. Guarana (Paullinia cupana) kuphucula ukudinwa kwizigulana ezinomhlaza wamabele ezenziwa kwinkqubo yenkqubo yemichiza. J Enye into yokuGqibezela iMed. NgoJuni ka-2011; 17: 505-12. Jonga i-abstract.
  16. UDa Costa Miranda V, uTrufelli DC, uSantos J, iLungu lePalamente laseCampos, uNobuo M, da Costa Miranda M, Schlinder F, Riechelmann R, del Giglio A.Ukusebenza kwe-guarana (Paullinia cupana) yokudinwa emva kwexesha kunye nokudakumba: iziphumo zomqhubi wenqwelomoya -ziimfama zokufunda ezingenamsebenzi. J Enye into yokuGqibezela iMed. Ngo-2009 kuMatshi; 15: 431-3. Jonga i-abstract.
  17. van der Hoeven N, Visser I, Schene A, van den Wazalelwa uBJ. Uxinzelelo lwegazi olunzulu olunxulumene nekhofi ene-caffeine kunye ne-tranylcypromine: ingxelo yetyala. UAnn Intern Med. Ngo-2014 ngoMeyi 6; 160: 657-8. ikhonkco: 10.7326 / L14-5009-8. Akukho nto ekhoyo. Jonga i-abstract.
  18. UPeng PJ, uChiang KT, uLiang CS. I-caffeine yedosi ephantsi inokuthi inyuse iimpawu zengqondo kubantu abane-schizophrenia. J Neuropsychiatry Iklinikhi yeNeurosci. 2014 kuMatshi 1; 26: E41. ikhonkco: 10.1176 / appi.neuropsych.13040098. Akukho nto ekhoyo. Jonga i-abstract.
  19. UBrice C noSmith A.Iziphumo zecaffeine ekuqhubeni okulingisiweyo, ukuphapha ngokujonga kunye nokugcina ingqalelo. Iiklinikhi zeHum Psychopharmacol Exp 2001; 16: 523-531.
  20. I-Bempong DK, i-Houghton PJ, kunye ne-Steadman K. Umxholo we-xanthine we-guarana kunye namalungiselelo ayo. I-Int J Pharmacog 1993; 31: 175-181.
  21. Marx, F. kunye et al. Uhlalutyo lweguaraná (
  22. I-Chamone, D.A, Silva, M.I, Cassaro, C., Bellotti, G., Massumoto, C.M, kunye neFujimura, A.Y. Guaraná (Paullinia cupana) inqanda ukudityaniswa kwegazi liphela. I-Thrombosis kunye neHaemostasis 1987; 58: 474.
  23. Rejent T, Michalek R, kunye noKrajewski M.Ukufa kweCaffeine kunye ne-ephedrine engqinelanayo. IBull Int Assoc Forensic Toxicol 1981; 16: 18-19.
  24. Khodesevick AP. Ityhefu yecaffeine ebulalayo (kwimeko yokusebenza). Ifama yeCololok Toksikol 1956; 19 (suppl): 62.
  25. UDrew AK kunye noDawson AH. I-Herbal xtreme: ityhefu ebukhali ehambelana ne-intravenous guarana [abstract]. Ijenali yeToxicology-Clinical Toxicology 2000; 38: 235-236.
  26. I-Ryall JE. Caffeine kunye nokufa kwe-ephedrine. IBull Int Assoc Forensic Toxicol 1984; 17: 13.
  27. Mattei, R., Dias, R. F., Espinola, E. B., Carlini, E. A., kunye no-Barros, S. B. Guarana (Paullinia cupana): Iziphumo zokuziphatha ezinobungozi kwizilwanyana zaselebhu kunye nomsebenzi we-antioxidants kwi-vitro. J. Ethnopharmacol. Ngo-1998; 60: 111-116. Jonga i-abstract.
  28. UGalduroz, J. C. noCarlini, E. A. Iziphumo zolawulo lwexesha elide lwe-guarana kulwazelelo lwamavolontiya aqhelekileyo. ISao Paulo Med. Ngo-1996; 114: 1073-1078. Jonga i-abstract.
  29. UBenoni, H., Dallakian, P., kunye noTaraz, K. Izifundo kwioyile ebalulekileyo evela kwi-guarana. Z. Lebensm.Unters.Forsch. Ngo-1996; 203: 95-98. Jonga i-abstract.
  30. UDebrah, K., Haigh, R., uSherwin, R., uMurphy, uJ, noKerr, D. Iziphumo zokusetyenziswa kwe-caffeine ebukhali kunye nengapheliyo kwi-cerebrovascular, cardiovascular and hormonal response to orthostasis kumavolontiya asempilweni. Iiklinikhi zeSci (Colch.) 1995; 89: 475-480. Jonga i-abstract.
  31. USalvadori, M. C., Rieser, E. M., Ribeiro Neto, L. M., kunye noNascimento, E. S. Ukugqitywa kwe-xanthines ngokusebenza okuphezulu kwe-chromatografi kunye ne-chromatography ecekeceke kumchamo wehashe emva kokungenisa umgubo weGuarana. Uhlalutyo 1994; 119: 2701-2703. Jonga i-abstract.
  32. UGalduroz, J. C. noCarlini, Ede A. Iziphumo ezibi zePaulinia cupana, "iGuarana" kukuqonda kwamavolontiya aqhelekileyo. ISao Paulo Med. Ngo-1994; 112: 607-611. Jonga i-abstract.
  33. UBelliardo, F., Martelli, A., kunye noValle, M. G. HPLC ukuzimisela kwe-caffeine kunye ne-theophylline ePaullinia cupana Kunth (guarana) naseCola spp. iisampulu. Z. Lebensm.Unters.Forsch. Ngowe-1985; 180: 398-401. Jonga i-abstract.
  34. I-Bydlowski, S. P., Yunker, R. L., kunye ne-Subbiah, M. T. Ipropathi yenoveli yesicatshulwa se-guarana esine-aqueous (Paullinia cupana): inhibition of platelet aggregation in vitro and in vivo. IBraz, J, iMed. IBiol, iRes. Ngo-1988; 21: 535-538. Jonga i-abstract.
  35. I-Bydlowski, S. P., D'Amico, E. A., kunye neChamone, D. A. Isicatshulwa esine-guarana (Paullinia cupana) sinciphisa iplatelet thromboxane synthesis. IBraz, J, iMed. IBiol, iRes. Ngo-1991; 24: 421-424. Jonga i-abstract.
  36. IHallerle, C. A., Jacob, P., kunye noBenowitz, N. L. Ixesha elifutshane lokuchaphazeleka kunye nefuthe lomdibaniso we-ephedra kunye ne-guarana indibaniselwano. Kwiklinikhi yeParmacol. Ngo-2005; 77: 560-571. Jonga i-abstract.
  37. UKennedy, D. O., Haskell, C. F., Wesnes, K., kunye no Scholey, A. B. Ukuphucula ukusebenza kwengqondo kumavolontiya angabantu emva kolawulo lwe-guarana (Paullinia cupana) ukukhupha: ukuthelekisa kunye nokusebenzisana ne-Panax ginseng. IPhemacol Biochem Behav 2004; 79: 401-411. Jonga i-abstract.
  38. UBaghkhani, L. kunye noJafari, M. Ukuphendula okungalunganga kwentliziyo okunxulunyaniswa neGuarana: ngaba kukho isiphumo sokuchaphazeleka? J. Herb. Umzi mveliso. Ngo-2002; 2: 57-61. Jonga i-abstract.
  39. UAvato, P., Pesante, M. A., Fanizzi, F. P., kunye no-Santos, C. A. Imbewu yeoyile yePaullinia cupana var. I-sorbilis (Mart) iDucke. Iipilisi ze-2003; 38: 773-780. Jonga i-abstract.
  40. USmith, A. P., Kendrick, A. M., kunye noMaben, A. L. Iziphumo zesidlo sakusasa kunye necaffeine ekusebenzeni nakwimo yexesha kusasa nasemva kwesidlo sasemini. I-Neuropsychobiology 1992; 26: 198-204 (PubMed) (Umnqamlezo) Jonga i-abstract.
  41. de Oliveira, JF, Avila, AS, Braga, AC, de Oliveira, MB, Boasquevisque, EM, Jales, RL, Cardoso, VN, kunye noBernardo-Filho, M. Iziphumo zokukhutshwa kwezityalo ezingamayeza ekubhaleni izinto zegazi kunye I-Technetium-99m kunye ne-morphology yeeseli ezibomvu zegazi: I - isifundo kunye noPaullinia cupana. UFitoterapia 2002; 73: 305-312. Jonga i-abstract.
  42. USmits, P., Corstens, F.H, Aengevaeren, W. R., Wackers, F. J., kunye noT Thien, T. Ubuxoki-gwenxa be-dipyridamole-thallium-201 i-imaging ye-myocardial emva kokufakwa kwe-caffeine. J Nucl, kunye noMed. Ngo-1991; 32: 1538-1541. Jonga i-abstract.
  43. du, Boisgueheneuc F., Lannuzel, A., Caparros-Lefebvre, D., noDe Broucker, T. [ICerebral infarction kwisigulana esidla isicatshulwa seMaHuang kunye neguarana]. Cwangcisa iMed 2-3-2001; 30: 166-167. Jonga i-abstract.
  44. Lloyd, T., Rollings, N., Eggli, D. F., Kieselhorst, K., kunye noChinchilli, V. M. Ukutya i-caffeine yokutya kunye nenqanaba leethambo labasetyhini be-postmenopausal. NdinguJ. Clin. Ngo-1997; 65: 1826-1830. Jonga i-abstract.
  45. ISicard, B. A., Perault, M. C., Enslen, M., Chauffard, F., Vandel, B., kunye noTachon, P. Iziphumo ze-600 mg yokukhupha kancinci icaffeine kwimood kunye nokuphaphama. Indawo yeNdawo yokuHamba.Ngo-1996; 67: 859-862. Jonga i-abstract.
  46. UMorano, A., Jimenez-Jimenez, F. J., Molina, J. A., noAntolin, M. A. Izinto ezinobungozi kwisifo sikaParkinson: isifundo solawulo lwamatyala kwiphondo laseCaceres, eSpain. Umthetho we-Neurol. I-1994; 89: 164-170. Jonga i-abstract.
  47. UBlanchard, uJ. Kunye noSawers, S. J. Ukufumaneka ngokupheleleyo kwe-caffeine emntwini. I-Eur. J. Clin. IPharmacol. Ngo-1983; 24: 93-98. Jonga i-abstract.
  48. I-Curatolo, P. W. kunye neRobertson, D. Iziphumo zempilo zecaffeine. UAnn. Interned. Ngo-1983; 98 (5 iPt 1): 641-653. Jonga i-abstract.
  49. I-Astrup, A., Toubro, S., Cannon, S., Hein, P., Breum, L., kunye neMadsen, J. Caffeine: isifundo esilawulwa yimfama, esilawulwa yi-placebo sonyango lwaso, imetabolism, kunye nefuthe lentliziyo. kumavolontiya asempilweni. NdinguJ. Clin. Ngo-1990; 51: 759-767. Jonga i-abstract.
  50. I-Pappa, HM, Saslowsky, TM, Filip-Dhima, R., DiFabio, D., Lahsinoui, HH, Akkad, A., Grand, RJ, kunye neGordon, CM Ukusebenza kunye nokwenzakala kwe-nasal calcitonin ekuphuculeni ukuxinana kwethambo kwizigulana ezisencinci. ngezifo zesisu ezivuthayo: ityala elilawulwa ngokungahleliwe, elilawulwa yi-placebo, elingaboni kabini. NdinguJ Gastroenterol. Ngo-2011; 106: 1527-1543. Jonga i-abstract.
  51. Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, ME, Becerril-Herrera, M., Hernandez-Gonzalez, R., kunye noVillanueva-Garcia, D. Iziphumo ze ukulawulwa kwecaffeine kwizinto eziguqulweyo zehagu zeentsana ezineepheripartum asphyxia. Ndingu. J Vet. Res. Ngo-2010; 71: 1214-1219. Jonga i-abstract.
  52. UClausen, T. IHormonal kunye nohlengahlengiso lwe-pharmacological yeplasma potassium homeostasis. IClin Pharmacol 2010; 24: 595-605. Jonga i-abstract.
  53. U-Ernest, D., Chia, M., kunye no-Corallo, C. E. I-hypokalaemia enzulu ngenxa yokusetyenziswa gwenxa kwe-Nurofen Plus kunye ne-Red Bull. Ukuhlaziywa kweCrit Care Resusc. Ngo-2010; 12: 109-110. Jonga i-abstract.
  54. UJha, R. M., Mithal, A., Malhotra, N., kunye noBrown, E. M. Pilot-lawulo lwamatyala ophando malunga nemingcipheko yokuqhekeka kwe-hip kwiindawo zaseIndiya zasezidolophini. BMC.Musculoskelet.Ukuphazamiseka. Ngo-2010; 11: 49. Jonga i-abstract.
  55. Rigato, I., Blarasin, L., kunye noKette, F.Ihypokalemia enzima kubagibeli beebhayisekile abancinci aba-2 ngenxa yokutya kakhulu ikhaffeine. Iiklinikhi J zeMidlalo. Ngo-2010; 20: 128-130. Jonga i-abstract.
  56. IBarbour, KE, Zmuda, JM, Strotmeyer, ES, Horwitz, MJ, Boudreau, R., Evans, RW, Ensrud, KE, Petit, MA, Gordon, CL, kunye noCauley, JA Correlates of trabecular and cortical volumetric bone mineral density yerediyo kunye ne-tibia kumadoda amadala: ii-Osteoporotic Fractures kuFundo lwaMadoda. J Bone Miner. I-2010; 25: 1017-1028 (PubMed) (Umnqamlezo) Jonga i-abstract.
  57. I-Buscemi, S., i-Verga, i-S, i-Batsis, i-JA, i-Donatelli, i-M, i-Tranchina, i-MR, i-Belmonte, i-S, i-Mattina, i-A, i-Re, i-A, ne-Cerasola, i-G. kwizifundo ezisempilweni. I-Eur. J yeNyango yeZonyango. Ngo-2010; 64: 483-489. Jonga i-abstract.
  58. I-Simmonds, M.J, Minahan, C.L, kunye neSabapathy, S. Caffeine iphucula ibhayisekile ephezulu kodwa hayi inqanaba lokukhululwa kwamandla kwe-anaerobic. I-Eur. J Appl yePhysol 2010; 109: 287-295. Jonga i-abstract.
  59. UJamal, SA, Swan, VJ, Brown, JP, Hanley, DA, Phambili, JC, Papaioannou, A., Langsetmo, L., noJosse, RG Umsebenzi wezintso kunye nenqanaba lokulahleka kwethambo esinqeni nasemqolo: iCanada Multicentre Isifundo se-Osteoporosis. NdinguJ Kidney Dis. Ngo-2010; 55: 291-299. Jonga i-abstract.
  60. IChroscinska-Krawczyk, M., Ratnaraj, N., Patsalos, P. N., kunye noCzuczwar, S. J. Iziphumo zecaffeine kwiziphumo ze-anticonvulsant ze-oxcarbazepine, lamotrigine kunye ne-tiagabine kwimodeli yegundane yokuthinjwa ngokubanzi kweetoni. IPhemacol Rep. 2009; 61: 819-826. Jonga i-abstract.
  61. UMoisey, uL. L., uRobinson, u-E, no-Graham, u-T. Ukusetyenziswa kwekofu ene-caffeine kunye nokutya okuphezulu kwe-carbohydrate kuchaphazela imetabolism yasemva kwexesha yokuvavanywa kweswekile yomlomo kulutsha olusempilweni. Br. J Isondlo. Ngo-2010; 103: 833-841. Jonga i-abstract.
  62. Waugh, EJ, Lam, MA, Hawker, GA, McGowan, J., Papaioannou, A., Cheung, AM, Hodsman, AB, Leslie, WD, Siminoski, K., kunye noJamal, SA Izinto ezinobungozi zamathambo asezantsi abasetyhini abanempilo abaneminyaka engama-40-60 ubudala: uphononongo olucwangcisiweyo loncwadi. Iinkcukacha Ngo-2009; 20: 1-21. Jonga i-abstract.
  63. IMacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., kunye noBaron, JA Iziphumo zeMetabolic kunye nehomoni yecaffeine: ilingo le-crossover elilawulwa yimfama. Imetabolism 2007; 56: 1694-1698. Jonga i-abstract.
  64. UHansen, S. A., Folsom, A. R., Kushi, L.H, kunye nabathengisi, T. A. Umbutho wokuqhekeka ne-caffeine kunye notywala kubafazi be-postmenopausal: I-Iowa Women's Health Study. Isondlo seMpilo yoLuntu. Ngo-2000; 3: 253-261. Jonga i-abstract.
  65. URobelin, M. kunye noRogers, P. J. Mood kunye nokusebenza kwengqondo kwiziphumo zokuqala, kodwa hayi ezalandelayo, ikomityi yekofu yedosi elinganayo yecaffeine esetyenzisiweyo emva kokuyeka ikhefeyini. Uhlobo lwePharmacol 1998; 9: 611-618. Jonga i-abstract.
  66. Rogers, P.J kunye neDernoncourt, C. Ukusetyenziswa rhoqo kwecaffeine: ibhalansi yeziphumo ezibi kunye eziluncedo kwimood kunye nokusebenza kwengqondo. I-Pharmacol Biochem, iBhahav. Ngo-1998; 59: 1039-1045. Jonga i-abstract.
  67. Stein, M.A, Krasowski, M., Leventhal, B. L., Phillips, W., kunye neBender, B. G. Iziphumo zokuziphatha kunye nokuqonda kwemethylxanthines. Uhlalutyo lweemeta lwe-theophylline kunye ne-caffeine. IArch.Pediatr.Adolesc.Med. Ngo-1996; 150: 284-288. Jonga i-abstract.
  68. ICaballero, T., Garcia-Ara, C., Pascual, C., Diaz-Pena, J. M., kunye no-Ojeda, A. Urticaria ebangelwa yi-caffeine. Uvavanyo lweAllergol, J. Clin. Ngo-1993; 3: 160-162. Jonga i-abstract.
  69. Tassaneeyakul, W., Birkett, DJ, McManus, ME, Tassaneeyakul, W., Veronese, ME, Andersson, T., Tukey, RH, kunye nabavukuzi, JO Caffeine metabolism by cytochromes hepatic human P450: iminikelo ye-1A2, 2E1 kunye ne-3A isoforms. Ingqondo. Pharmacol 5-18-1994; 47: 1767-1776. Jonga i-abstract.
  70. Iiparsons, uW. D. kunye nePelletier, J. G. Ukulibaziseka kokupheliswa kwecafine ngabafazi kwiiveki ezi-2 zokugqibela zokukhulelwa. Ngaba. Med. Assoc. J 9-1-1982; 127: 377-380. Jonga i-abstract.
  71. UBlanchard, J. kunye noSawers, S. J. Thelekisa i-pharmacokinetics ye-caffeine emadodeni nakwabadala. J Pharmacokinet kunye neBiopharm. Ngo-1983; 11: 109-126. Jonga i-abstract.
  72. UGrant, D. M., Tang, B. K., kunye noKalow, W. Umahluko kwimetabolism ye-caffeine. KwiKlinikhi ye-Pharmacol Ther 1983; 33: 591-602. Jonga i-abstract.
  73. Iiparsons, uW. D. kunye neeNeims, A. H. Iziphumo zokutshaya kugcino lwecaffeine. KwiKlinikhi ye-Pharmacol Ther 1978; 24: 40-45. Jonga i-abstract.
  74. Keuchel, I., Kohnen, R., kunye no Lienert, G. A. Iziphumo zotywala kunye necaffeine ekusebenzeni kovavanyo loxinzelelo. Iifayile. Ngo-1979; 29: 973-975. Jonga i-abstract.
  75. UArnold, M. E., Petros, T. V., Beckwith, B. E., Coons, G., noGorman, N. Iziphumo zecaffeine, ukungxamiseka, kunye nokwabelana ngesondo kwimemori kuluhlu lwamagama. UPhysiol Behav. Ngowe-1987; 41: 25-30. Jonga i-abstract.
  76. URobertson, D., Frolich, J. C., Carr, R. K., Watson, J. T., Hollifield, J. W., Shand, D. G., kunye no-Oates, J. A. Iziphumo ze-caffeine kwimisebenzi ye-plasma renin, i-catecholamines kunye noxinzelelo lwegazi. UEngl. J Med. I-1-26-1978; 298: 181-186. Jonga i-abstract.
  77. UPola, J., Subiza, J., Armentia, A., Zapata, C., Hinojosa, M., Losada, E., noValdivieso, R. Urticaria ebangelwa yi-caffeine. UAnn. Utyando ngo-1988; 60: 207-208. Jonga i-abstract.
  78. Wrenn, K. D. kunye no-Oschner, I. Rhabdomyolysis ebangelwa yi-caffeine overdose. UAn Ann Emmed. Ngo-1989; 18: 94-97. Jonga i-abstract.
  79. UQuirce, G. S., Freire, P., Fernandez, R. M., Davila, mna, noLosada, E. Urticaria ovela kwi-caffeine. J. Utyando lweKlinikhi Immunol. Ngo-1991; 88: 680-681. Jonga i-abstract.
  80. Yu, G., Maskray, V., Jackson, S. H., Swift, C. G., kunye noTiplady, B. Ukuthelekiswa kwenkqubo ye-nervous system ye-caffeine kunye ne-theophylline kwizifundo zabantu abadala. UBr. J Clin Pharmacol 1991; 32: 341-345. Jonga i-abstract.
  81. URoberts, T., Jonge-Levitan, L., Parker, C., kunye noGreenway, F. Iziphumo zesongezelelo semifuno esiqukethe iti emnyama kunye ne-caffeine kwiiparameter zemetabolism ebantwini. Enye iMed Rev 2005; 10: 321-325. Jonga i-abstract.
  82. UBryant, uC. M., uDowell, uC. J., kunye noFairbrother, uG. UBr. J. Nurs. 4-25-2002; 11: 560-565. Jonga i-abstract.
  83. Conlisk, A. Edlulileyo. Ngo-2000; 31: 562-568. Jonga i-abstract.
  84. UArya, L.A, Myers, D. L., kunye noJackson, N. D. Ukutya ikhafeyini yokutya kunye nomngcipheko wokungazinzisi kwe-detrusor: isifundo solawulo lwamatyala. Isibambiso. Ngo-2000; 96: 85-89. Jonga i-abstract.
  85. U-Liu, u-T. Kunye no-Liau, uJ. I-Caffeine yonyusa ubume bempendulo ye-BOLD ebonakalayo. Imvelaphi. 2-1-2010; 49: 2311-2317. Jonga i-abstract.
  86. Ursing, C., Wikner, J., Brismar, K., kunye noRojdmark, S. Caffeine iphakamisa inqanaba le-serum melatonin kwizifundo ezisempilweni: uphawu lwe-melatonin metabolism yi-cytochrome P450 (CYP) 1A2. J. Endocrinol. Utyalomali 2003; 26: 403-406. Jonga i-abstract.
  87. IHartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., kunye noLaine, K. Iziphumo zokutya kwe-caffeine kwi-pharmacokinetics ye-melatonin, iyeza lokuphanda lomsebenzi we-CYP1A2. Br. J. Clin, iPharmacol. 2003; 56: 679-682. Jonga i-abstract.
  88. UZheng, J., Chen, B., Jiang, B., Zeng, L., Tang, Z. R., Fan, L., noZhou, H. H. Iziphumo ze-puerarin kwi-CYP2D6 kunye nemisebenzi ye-CYP1A2 kwi-vivo. IArch Pharm Res 2010; 33: 243-246. Jonga i-abstract.
  89. Chen, Y., Xiao, CQ, He, YJ, Chen, BL, Wang, G., Zhou, G., Zhang, W., Tan, ZR, Cao, S., Wang, LP, kunye noZhou, HH Genistein kuguqula ukubonakaliswa kwe-caffeine kumavolontiya asempilweni abantu ababhinqileyo. Iikliniki ze-Eur. J. Pharmacol. Ngo-2011; 67: 347-353. Jonga i-abstract.
  90. Gorski, JC, Huang, SM, Pinto, A., Hamman, MA, Hilligoss, JK, Zaheer, NA, Desai, M., Miller, M., kunye neHolo, SD Iziphumo ze-echinacea (Echinacea purpurea ingcambu) kwi-cytochrome Umsebenzi we-P450 kwi-vivo. KwiKlinikhi ye-Pharmacol Ther. Ngo-2004; 75: 89-100. Jonga i-abstract.
  91. U-Wang, X. kunye no-Yeung, J. H. Iziphumo zokukhutshwa kwamanzi eSalvia miltiorrhiza Bunge kwi-caffeine pharmacokinetics nakwisibindi microsomal CYP1A2 umsebenzi ebantwini nasezimpuku. UJ Pharm Pharmacol 2010; 62: 1077-1083. Jonga i-abstract.
  92. UNorager, C. B., Jensen, M. B., Weimann, A., kunye noMadsen, M. R. Iziphumo zeMetabolic zokungenisa i-caffeine kunye nokusebenza komzimba kubemi abaneminyaka engama-75 ubudala. Isifundo esingahleliwe, esingaboniyo, esilawulwa yi-placebo, esifundweni esingaphaya kokufunda. Iiklinikhi ze-Endocrinol (Oxf) 2006; 65: 223-228. Jonga i-abstract.
  93. UDaniel, W. A., uSyrek, M., uRylko, Z., noKot, M. Iziphumo ze-phenothiazine neuroleptics kwinqanaba le-caffeine demethylation kunye ne-hydroxylation kwisibindi sempuku. Ipol. J Pharmacol 2001; 53: 615-621. Jonga i-abstract.
  94. UWojcikowski, J. noDaniel, W. A. ​​Perazine kunyango lweziyobisi ekuthinteleni i-cytochrome P450 isoenzyme 1A2 (CYP1A2) kunye ne-caffeine metabolism-in vitro Study. IPhemacol Rep. 2009; 61: 851-858. Jonga i-abstract.
  95. Mays, D., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., kunye noGerber, N. Methoxsalen sisithintelo esinamandla semetabolism ye-caffeine ebantwini. Kwiklinikhi yeParmacol. Ngowe-1987; 42: 621-626. Jonga i-abstract.
  96. Mohiuddin, M., Azam, A. T., Amran, M. S., kunye noHossain, M. A. Kwiziphumo ezibonakalayo ze-gliclazide kunye ne-metformin kwi-plasma ye-caffeine kwiigundane ezisempilweni. Pak. J Biol Sci 5-1-2009; 12: 734-737 (PubMed) (Umnqamlezo) Jonga i-abstract.
  97. Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., kunye noCzuczwar, SJ Felbamate ibonisa ukuthambeka okuphantsi kokunxibelelana ne-methylxanthines kunye ne-Ca2 + iimodyuli zesiteshi ngokuchasene nokuvavanywa kovavanyo kwiimpuku. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Jonga i-abstract.
  98. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Impembelelo ye-caffeine kwiprofayili ye-pharmacokinetic ye-sodium valproate kunye ne-carbamazepine kumavolontiya aqhelekileyo abantu. Indiya J.Exp. Ibhayol. Ngo-1998; 36: 112-114. Jonga i-abstract.
  99. IChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., kunye noCzuczwar, S. J. Caffeine kunye namandla e-anticonvulsant amachiza e-antiepileptic: idatha yovavanyo kunye neklinikhi. IPhemacol. Ngo-2011; 63: 12-18. Jonga i-abstract.
  100. ILuszczki, J., Zuchora, M., Sawicka, K. M., Kozinska, J., kunye noCzuczwar, S. J. Ukuvezwa ngokukuko kwi-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kodwa hayi eyokuxhamla kwe-clonazepam, phenobarbital kunye ne-valproate ngokuchasene ne-pentetrazole-induction seiz. IPhemacol Rep. 2006; 58: 652-659. Jonga i-abstract.
  101. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., kunye noCzuczwar, S. J. [Caffeine kunye neziyobisi ezichasene ne-antiepileptic: idatha yovavanyo kunye neklinikhi]. Przegl.Ilek. Ngo-2007; 64: 965-967. Jonga i-abstract.
  102. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., kunye noCzuczwar, S. J. Umsebenzi weAnticonvulsant we-phenobarbital kunye ne-valproate ngokuchasene ne-electroshock ephezulu kwiimpuku ngexesha lonyango olungapheliyo kunye ne-caffeine kunye ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Jonga i-abstract.
  103. UKot, M. noDaniel, W. A. ​​Iziphumo ze-diethyldithiocarbamate (DDC) kunye ne-ticlopidine kwimisebenzi ye-CYP1A2 kunye ne-caffeine metabolism: isifundo se-vitro sokuthelekisa kunye ne-cDNA yomntu-echazwe i-CYP1A2 kunye ne-microsomes yesibindi. IPhemacol Rep. 2009; 61: 1216-1220. Jonga i-abstract.
  104. Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., kunye no-Estabrook, R. W. Metabolism weziyobisi ze-antiandrogenic (Flutamide) yi-CYP1A2 yabantu. Ukuchithwa kweMetab yeziyobisi. Ngo-1997; 25: 1298-1303. Jonga i-abstract.
  105. IKynast-Gales SA, iMassey LK. Iziphumo zecaffeine kwi-circadian excretion ye-urinary calcium kunye ne-magnesium. J NdinguColl Nutraki. Ngo-1994; 13: 467-72. Jonga i-abstract.
  106. I-Spinella M. Amayeza e-Herbal kunye ne-Epilepsy: Amandla okufumana izibonelelo kunye neziphumo ezibi. Isifo sokuwa uBev 2001; 2: 524-532. Jonga i-abstract.
  107. I-Mansi IA, i-Huang J. Rhabdomyolysis ekuphenduleni kokunciphisa umzimba ngamayeza e-herbal. NdinguJ Med Sci 2004; 327: 356-357. Jonga i-abstract.
  108. USavitz DA, uChan RL, uHering AH, et al. I-caffeine kunye nomngcipheko wokuphuma kwesisu. I-Epidemiology 2008; 19: 55-62. Jonga i-abstract.
  109. U-Weng X, u-Odouli R, u-Li DK. Ukusetyenziswa kwecaffeine yoomama ngexesha lokukhulelwa kunye nomngcipheko wokukhulelwa kwesisu: isifundo esinokubakho seqela. Ndingu-J Obstet Gynecol 2008; 198: 279.e1-8. Jonga i-abstract.
  110. URobinson LE, uSavani S, uBattram DS, et al. Ukungenisa i-caffeine ngaphambi kovavanyo lokunyamezelwa kweswekile yomlomo kuphazamisa ulawulo lweglucose yegazi kumadoda ane-2 yeswekile. J Amanqatha 2004; 134: 2528-33. Jonga i-abstract.
  111. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amanqanaba e-plasma caffeine. KwiKlinikhi ye-Pharmacol Ther 1990; 47: 675-85. Jonga i-abstract.
  112. I-Forrest WH Jr, iBellville JW, uBrown BW Jr.Ukusebenzisana kwe-caffeine kunye ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Jonga i-abstract.
  113. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Iziphumo zecaffeine equlathe ikofu enganyibilikiweyo kwindawo ekugxininiswe kuyo i-serum clozapine kwizigulana ezibhedlele. Isiseko seKlinikhi yePhemacol Toxicol 2004; 94: 13-8. Jonga i-abstract.
  114. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukwahlulahlulahlulwa komzimba okwandisiweyo, iimpendulo zehomoni kunye nokuqonda kwi-hypoglycaemia ngokusetyenziswa kwecaffeine okuzinzileyo. Iiklinikhi yeSci (uLond) 2003; 104: 447-54. Jonga i-abstract.
  115. IWinkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukutya okuqhelekileyo kwe-caffeine kunye nomngcipheko wexinzelelo lwexinzelelo kubafazi. IJAMA 2005; 294: 2330-5. Jonga i-abstract.
  116. UJuliano LM, noGriffiths RR. Uphengululo olubalulekileyo lokurhoxiswa kwecaffeine: ubungqina bokuqina kweempawu kunye neempawu, izehlo, ubungqongqo, kunye neempawu ezinxulumene noko. Ingqondo yePsychopharmacology (Berl) 2004; 176: 1-29. Jonga i-abstract.
  117. I-Leson CL, McGuigan MA, iBryson SM. I-caffeine overdose kwindoda efikisayo. J Ityhefu yeklinikhi yetyhefu 1988; 26: 407-15. Jonga i-abstract.
  118. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhutshwa kwe-catecholamine enkulu kwi-caffeine yetyhefu. IJAMA 1982; 248: 1097-8. Jonga i-abstract.
  119. UAcheson KJ, uGremaud G, Meirim I, et al. Iziphumo zeMetabolic zecaffeine ebantwini: i-lipid oxidation okanye ibhayisekile engenamsebenzi? NdinguJ J Clin Nutriti 2004; 79: 40-6. Jonga i-abstract.
  120. IHallerle CA, uBenowitz NL, uJacob P 3rd. Iziphumo zeHemodynamic ze-ephedra-free-weight loss-supplements ebantwini. NdinguJ Med 2005; 118: 998-1003 .. Jonga i-abstract.
  121. UPetrie HJ, uChown SE, uBelfie LM, et al. Ukungenisa kweCaffeine kwandisa impendulo ye-insulin kuvavanyo lomlomo-lweswekile-ukunyamezeleka kumadoda atyebileyo ngaphambi nasemva kokuphulukana nobunzima. NdinguJ J Clin Nutriti 2004; 80: 22-8. Jonga i-abstract.
  122. Umgaqo JD, Barkauskas CE, Surwit RS, Feinglos MN. I-caffeine yonakalisa imetabolism yohlobo lwe-2 lweswekile. Unonophelo lweSwekile 2004; 27: 2047-8. Jonga i-abstract.
  123. UAndersen T, uFogh J. Ukwehla kobunzima kunye nokulibaziseka kokukhupha isisu kulandela ukulungiswa kwamayeza ase Mzantsi Melika kwizigulana ezityebe kakhulu. Isidlo seJ Hum esisondlo 2001; 14: 243-50. Jonga i-abstract.
  124. ICannon ME, Cooke CT, McCarthy JS. I-Caffeine-india arrhythmia yentliziyo: ingozi engaziwayo yemveliso yokutya kwezempilo. UMed J Aust 2001; 174: 520-1. Jonga i-abstract.
  125. IDews PB, O'Brien CP, Bergman J. Caffeine: Iziphumo zokuziphatha zokurhoxa kunye nemicimbi ehambelana nayo. Ukutya iChem Toxicol 2002; 40: 1257-61. Jonga i-abstract.
  126. IHolmgren P, i-Norden-Pettersson L, i-Ahlner J. Caffeine yokusweleka-iingxelo zamatyala amane. I-Forensic Sci Int 2004; 139: 71-3. Jonga i-abstract.
  127. UChou T. Vuka kwaye unuke ikofu. Caffeine, ikofu, kunye neziphumo zonyango. INtshona J Med 1992; 157: 544-53. Jonga i-abstract.
  128. IHowell LL, iCoffin VL, iSpealman RD. Ukuziphatha kunye nefuthe lomzimba le-xanthines kwizidalwa ezingezizo ezomntu. I-Psychopharmacology (Berl) 1997; 129: 1-14. Jonga i-abstract.
  129. Iziko lezeMpilo. I-Caffeine yoLondolozo lweNtsebenzo yeNgqondo yokuSebenza: Iifom zokuSebenza koMkhosi. IWashington, DC: I-National Academy Press, 2001. Iyafumaneka apha: http://books.nap.edu/books/0309082587/html/index.html.
  130. UZheng XM, uWilliam RC. Amanqanaba e-caffeine ye-serum emva kokungabikho kweyure ye-24: iimpembelelo zeklinikhi kwi-dipyridamole Tl ye-myocardial imaging perfusion. J Nucl Med Technol 2002; 30: 123-7. Jonga i-abstract.
  131. I-Aqel RA, iZoghbi GJ, iTrimm JR, et al. Iziphumo zecaffeine elawulwa ngaphakathi ngaphakathi ngaphakathi kwi-adenosine-eyanyanzeliswa yi-coronary hemodynamics kwizigulana ezinesifo semithambo. NdinguJ Cardiol 2004; 93: 343-6. Jonga i-abstract.
  132. Ngaphantsi kwe-DA. Ngawaphi amayeza ekufuneka abanjwe ngaphambi kovavanyo lwe-pharmacologic okanye lovavanyo lokuzivocavoca? Iklinikhi yokuCoca uJ Med 2002; 69: 449-50. Jonga i-abstract.
  133. USmith A.Iziphumo zecaffeine ekuziphatheni komntu. Ukutya kweKhem Toxicol 2002; 40: 1243-55. Jonga i-abstract.
  134. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine nge-dipyridamole-thallium-201 imaging ye-myocardial. Unyango ngo-1995; 29: 425-7. Jonga i-abstract.
  135. UCarrillo JA, uBenitez J.Ukusebenzisana kweekhemikhali phakathi kwecafine yokutya kunye namayeza. Kwiiklinikhi zeFarmacokinet 2000; 39: 127-53. Jonga i-abstract.
  136. I-Wahllander A, Paumgartner G. Iziphumo ze-ketoconazole kunye ne-terbinafine kwi-pharmacokinetics ye-caffeine kumavolontiya asempilweni. I-Eur J Clin Pharmacol 1989; 37: 279-83. Jonga i-abstract.
  137. USanderink GJ, uBournique B, uStevens J, et al. Ukubandakanyeka kwe-CYP1A isoenzymes yomntu kwimetabolism kunye nokunxibelelana kweziyobisi kwe-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Jonga i-abstract.
  138. I-Brown NJ, i-Ryder D, i-RA yesebe. Unxibelelwano lwe-pharmacodynamic phakathi kwe-caffeine kunye ne-phenylpropanolamine. KwiKlinikhi ye-Pharmacol Ther 1991; 50: 363-71. Jonga i-abstract.
  139. I-Abernethy DR, Todd EL.Ukuphazamiseka kwendlela yokucoca i-caffeine ngokusetyenziswa okungapheliyo kweedosi ezisezantsi ezine-contraceptive zomlomo. I-Eur J Clin Pharmacol 1985; 28: 425-8. Jonga i-abstract.
  140. NgoMeyi DC, uJarboe CH, uVanBakel AB, uWilliam WM. Iziphumo ze-cimetidine kwindawo ye-caffeine kubantu abatshayayo nakwabo bangatshayiyo. KwiKlinikhi ye-Pharmacol Ther 1982; 31: 656-61. Jonga i-abstract.
  141. UNawrot P, iJordani S, i-Eastwood J, et al. Iziphumo zecaffeine kwimpilo yabantu. Ukongezwa kokutya kwiContam 2003; 20: 1-30. Jonga i-abstract.
  142. IMassey LK, iWhiting SJ. I-caffeine, i-calcium yokuchama, i-calcium metabolism kunye nethambo. J Amanqatha 1993; 123: 1611-4. Jonga i-abstract.
  143. I-Infante S, iBaeza ML, iCalvo M, okqhubekayo. I-Anaphylaxis ngenxa ye-caffeine. Ukunyuka komzimba ngo-2003; 58: 681-2. Jonga i-abstract.
  144. UNix D, uZelenitsky S, uSymonds W, et al. Iziphumo zefluconazole kwi-pharmacokinetics ye-caffeine kwizifundo ezincinci nezindala. Kwiklinikhi ye-Pharmacol Ther 1992; 51: 183.
  145. I-Schechter MD, iiTimons GD. Ukulinganiswa ngokungqinelanayo ne-hyperactivity-II. Caffeine kunye neamphetamine. J Clin Pharmacol 1985; 25: 276-80 .. Jonga i-abstract.
  146. IKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba kunye nokungaphenduli emva kokungenisa i-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Jonga i-abstract.
  147. IGrandjean AC, iReimers KJ, iBannick KE, iHaven MC. Iziphumo ze-caffeine, ezingenayo i-caffeine, i-caloric kunye ne-non-caloric iziyobisi kwi-hydration. J NdinguColl Nutriti 2000; 19: 591-600 .. Jonga i-abstract.
  148. I-Kamimori GH, iPenetar DM, iNtloko ye-DB, et al. Iziphumo zeedosi ezintathu zecaffeine kwii-catecholamines zeplasma kunye nokuphaphama ngexesha lokuvuka ixesha elide. I-Eur J Clin Pharmacol 2000; 56: 537-44 .. Jonga i-abstract.
  149. UDreher HM. Iziphumo zokuncitshiswa kwe-caffeine kumgangatho wokulala kunye nokuba sempilweni kwabantu abane-HIV. J Psychosom Res 2003; 54: 191-8 .. Jonga okungafakwanga.
  150. IMassey LK. Ngaba icaffeine ingumngcipheko wokulahleka kwethambo kubantu abadala? NdinguJ J Clin Nutr 2001; 74: 569-70. Jonga i-abstract.
  151. UChen JF, uXu K, uPetzer JP, et al. I-Neuroprotection yi-caffeine kunye ne-A (2A) ye-adenosine receptor inactivation kwimodeli yesifo sika-Parkinson. J Neurosci 2001; 21: RC143 .. Jonga i-abstract.
  152. I-Nehlig A, i-Debry G. Iziphumo zosana olusanda kuzalwa lokusela okungapheliyo koomama ngexesha lokukhulelwa kunye nokuncancisa: uphononongo. J NdinguColl Nutriti 1994; 13: 6-21 .. Jonga okungafakwanga.
  153. UMcGowan JD, Altman RE, Kanto WP Jr.Iimpawu zokurhoxa kweNeonatal emva kokungena komama okungapheliyo kwecaffeine. UMzantsi Med J 1988; 81: 1092-4 .. Jonga okungafakwanga.
  154. IBara AI, iBarley EA. Caffeine yesifuba. Isiseko sedatha yeCochrane Syst Rev 2001; 4: CD001112 .. Jonga i-abstract.
  155. IBracken MB, iTriche EW, Belanger K, et al. Umbutho wokusetyenziswa kwecaffeine koomama kunye nokuhla kokukhula komntwana. NdinguJ Epidemiol 2003; 157: 456-66 .. Jonga i-abstract.
  156. IPorner NK, iLampe JW. Iindlela ezinokubakho zonyango lokutya kwiimeko zebele le-fibrocystic zibonisa ubungqina obungonelanga bokusebenza. J Nditya i-Assoc 2000; 100: 1368-80. Jonga i-abstract.
  157. I-Bell DG, i-Jacobs I, i-Ellerington K. Iziphumo ze-caffeine kunye ne-ephedrine yokungenisa ukusebenza kwe-anaerobic. Ukuzivocavoca kweMed Sci Exerc 2001; 33: 1399-403. Jonga i-abstract.
  158. IGreenway FL, iRaum WJ, iDeLany JP. Iziphumo zokongezwa kwemithi yokutya okune-ephedrine kunye ne-caffeine ekusebenziseni ioksijini ebantwini. J Enye into yokuGqibezela iMed 2000; 6: 553-5. Jonga i-abstract.
  159. IHallerle CA, uJacob P 3rd, uBenowitz NL. I-Pharmacology ye-ephedra alkaloids kunye ne-caffeine emva kokusetyenziswa kwethamo elinye lokutya. KwiKlinikhi ye-Pharmacol Ther 2002; 71: 421-32. Jonga i-abstract.
  160. I-Avisar R, i-Avisar E, i-Weinberger D. Iziphumo zokusetyenziswa kwekofu kuxinzelelo lwe-intraocular. UAnn Pharmacother 2002; 36: 992-5 .. Jonga i-abstract.
  161. UFerrini RL, uBarrett-Connor E.Icaffeine yokutya kunye nenqanaba lesini le-steroid elingapheliyo kubafazi be-postmenopausal. Isifundo seRancho Bernardo. NdinguJ Epidemiol 1996: 144: 642-4. Jonga i-abstract.
  162. UArdlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Inhibition kunye nokubuyiselwa umva kweplatelet aggregation yi-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Jonga i-abstract.
  163. UAli M, Afzal M. Isithinteli esinamandla se-thrombin evuselelekileyo yeplatelet thromboxane ekwakhiweni kweti engagqitywanga. Iprostaglandins Leukot Med 1987; 27: 9-13. Jonga i-abstract.
  164. IHallerle CA, iBenowitz NL. Iziganeko zenkqubo ye-cardiovascular and central system ehambelana nezongezelelo zokutya eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Jonga i-abstract.
  165. USuleman A, uSiddiqui NH. Iziphumo ze-haemodynamic kunye neentliziyo zecaffeine. Amayeza kwi-Intanethi Int J Medicine 2000. www.priory.com/pharmol/caffeine.htm (Ifumaneka nge-14 ku-Epreli 2000).
  166. USinclair CJ, uGiiger JD. Ukusetyenziswa kweCaffeine kwezemidlalo. Uphengululo lwekhemesti. J Ezemidlalo ngokuDinwa komzimba 2000; 40: 71-9. Jonga i-abstract.
  167. UBourin M, uBougerol T, uGuitton B, uBroutin E.Umdibaniso wezicatshulwa zezityalo kunyango lwabangaphandle kunye nohlengahlengiso loxinzelelo kunye noxinzelelo: isifundo esilawulwayo vs placebo. IFundam Clin Pharmacol 1997; 11: 127-32. Jonga i-abstract.
  168. IAmerican Academy yeZilwanyana. Ukuhanjiswa kweziyobisi kunye nezinye iikhemikhali kubisi lomntu. Iipedatifikethi 2001; 108: 776-89. Jonga i-abstract.
  169. ULloyd T, uJohnson-Rollings N, uEggli DF, et al. Ubume bethambo phakathi kwabafazi abasemva kwemiphefumlo abanendlela eyahlukeneyo yokuthatha ikhaffeine: uphando olude. J Ndingu-Coll Nutrut 2000; 19: 256-61. Jonga i-abstract.
  170. UWatson JM, uJenkins EJ, uHamilton P, et al. Impembelelo ye-caffeine kwisantya kunye nokuqonda kwe-hypoglycemia kwizigulana ezihlala simahla ezine-1 yeswekile. Unonophelo lweSwekile 2000; 23: 455-9. Jonga i-abstract.
  171. UTobias JD. I-caffeine kunyango lwe-apnea enxulunyaniswa nosulelo lokuphefumla lwentsholongwane kwi-neonates nakwiintsana. UMzantsi Med J 2000; 93: 297-304. Jonga i-abstract.
  172. URoss GW, Abbott RD, uPetrovitch H, et al. Umbutho wekofu kunye nokutya kwe-caffeine kunye nomngcipheko wesifo se-parkinson. IJAMA 2000; 283: 2674-9. Jonga i-abstract.
  173. IHagg S, Spigset O, Mjorndal T, Dahlqvist R. Iziphumo zecaffeine kwi-clozapine pharmacokinetics kumavolontiya asempilweni. UBr J Clin Pharmacol 2000; 49: 59-63. Jonga i-abstract.
  174. Ikhowudi yeKhompyuter yeMigaqo yeFederal. Itayitile 21. Icandelo le-182 -Iziyobisi zivunywa ngokubanzi njengezikhuselekileyo. Ifumaneka kwi: https://www.accessdata.fda.gov/script/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  175. UWilliam MH, isebe JD. Yenza ukuxhaswa kunye nokusebenza komsebenzi: ukuhlaziywa. NdinguColl Nutriti 1998; 17: 216-34. Jonga i-abstract.
  176. IiBriggs GB, iFreeman RK, iYaffe SJ. Iziyobisi ekukhulelweni naseLactation. Umhla we-5. IPhiladelphia, PA: Lippincott Williams kunye noWilkins; Ngo-1998.
  177. UBozer CN, uNasser JA, uHeymsfield SB, et al. Isongezelelo semifuno esineMa Huang-Guarana yokunciphisa umzimba: ityala elingenamsebenzi, elingaboni kabini. I-Int J Obes edibanisa iMetab Disord 2001; 25: 316-24. Jonga i-abstract.
  178. I-FDA. Umgaqo ocetywayo: izongezo zokutya eziqukethe i-ephedrine alkaloids. Ifumaneka kwi: www.verity.fda.gov (Ifumaneka nge-25 Januwari 2000).
  179. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuphindaphindeka kokurhoxiswa kwe-caffeine kuvavanyo olusekwe kubemi nakwilingo elilawulwayo, elingaboniyo. J Clin Pharmacol 1999; 39: 1221-32. Jonga i-abstract.
  180. INurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikofu, icaffeine kunye noxinzelelo lwegazi: uphononongo olunzulu. I-Eur J yeKlinikhi yeNutrig 1999; 53: 831-9. Jonga i-abstract.
  181. I-Rees K, Allen D, Lader M.Iimpembelelo zobudala kunye ne-caffeine kwi-psychomotor kunye nokusebenza kwengqondo. I-Psychopharmacology (Berl) 1999; 145: 181-8 (PubMed) (Umnqamlezo) Jonga i-abstract.
  182. UDiPiro JT, uTalbert RL, uYe GC, et al; ii-eds. I-Pharmacotherapy: Indlela ye-pathophysiologic. Ngomhla we-4. IStamford, CT: IAppleton kunye neLange, 1999.
  183. IPollock BG, uWylie M, uStack JA, et al. Ukuthintela i-caffeine metabolism ngonyango lwe-estrogen endaweni yabasetyhini abasemva kwemasopaopausal. J Clin Pharmacol 1999; 39: 936-40. Jonga i-abstract.
  184. I-Wemple RD, iMvana DR, McKeever KH. I-Caffeine vs i-caffeine -simahla iziselo zemidlalo: Iziphumo kwimveliso yokuchama ekuphumleni nasekuzilolongeni ixesha elide. I-Int J Sports Med 1997; 18: 40-6. Jonga i-abstract.
  185. IStookey JD. Iziphumo zokuchama kotywala kunye necaffeine kunye nokungeniswa kwamanzi ngokungagungqiyo. I-Eur J Epidemiol 1999; 15: 181-8. Jonga i-abstract.
  186. UFernandes O, uSabharwal M, uSmiley T, et al. Ukumodareyitha ukuya ekusetyenzisweni kakhulu kwecaffeine ngexesha lokukhulelwa kunye nokunxibelelana nokuqhomfa okuzenzekelayo kunye nokukhula okungaqhelekanga komntwana: uhlalutyo lweemeta. Ukuhlaziya iTyhefu ka-1998; 12: 435-44. Jonga i-abstract.
  187. U-Eskenazi B. Caffeine-ukucoca iinyani. U-Eng Eng J Med 1999; 341: 1688-9. Jonga i-abstract.
  188. UKlebanoff MA, uLeviine RJ, uDerSimonian R, et al. I-serum paraxanthine yoomama, i-caffeine metabolite, kunye nomngcipheko wokuqhomfa okuzenzekelayo. U-Eng Eng J Med 1999; 341: 1639-44. Jonga i-abstract.
  189. Inkqubo yeSizwe yetyhefu (NTP). Icaffeine. Iziko loVavanyo loMngcipheko kuKwenziwa ngokutsha kwaBantu (CERHR). Ifumaneka kwi: http://cerhr.niehs.nih.gov/common/caffeine.html.
  190. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukutya kweCaffeine kunyusa inqanaba lokulahleka kwethambo kubafazi abadala kwaye kunxibelelana ne-vitamin D receptor genotypes. NdinguJ J Clin Nutr 2001; 74: 694-700. Jonga i-abstract.
  191. UChiu KM. Ukusebenza kwe-calcium yongeza kwisithambo kubasetyhini abase-postmenopausal. J Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Jonga i-abstract.
  192. UVandeberghe K, uGillis N, uVan Leemputte M, et al. I-caffeine ichasene nesenzo se-ergogenic yokulayisha ukulayishwa kwezihlunu. J Appl uPhysiol 1996; 80: 452-7. Jonga i-abstract.
  193. Ukutolikwa koVavanyo lovavanyo. Isishwankathelo seLebhu yelebhu. Eyesihlanu ed; IBoston, MA: Encinci kaBrown, ngo-1992.
  194. IHodgson JM, iPuddey IB, uBurke V, et al. Iziphumo kuxinzelelo lwegazi lokusela iti eluhlaza kunye emnyama. J Hypertens 1999; 17: 457-63 (PubMed) (Umnqamlezo) Jonga i-abstract.
  195. Wakabayashi K, Kono S, Shinchi K, okqhubekayo. Ukusetyenziswa kwesiqhelo kwekofu kunye noxinzelelo lwegazi: Uphononongo lwamagosa okuzikhusela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Jonga i-abstract.
  196. Kwidayethi, Phantse iLahleko yokuGqibela. IWashington Post. Ifumaneka kwi: http://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Ifumaneka nge-19 Matshi 2000 ).
  197. UVahedi K, uDomingo V, uAmarenco P, uBousser MG. Ischemic stroke kwimbaleki esebenzise i-MaHuang isicatshulwa kunye nokudala i-monohydrate yokwakha umzimba. J Neurolurosuroski yengqondo 2000; 68: 112-3. Jonga i-abstract.
  198. UJoeres R, uKlinker H, uHeusler H, et al. Impembelelo ye-mexiletine ekupheliseni i-caffeine. IPhemacol Ther 1987; 33: 163-9. Jonga i-abstract.
  199. UBreum L, uPedersen JK, uAhlstrom F, et al. Thelekisa i-ephedrine / indibaniselwano ye-caffeine kunye ne-dexfenfluramine kunyango lokutyeba kakhulu. Ityala eliphakathi elingaboniyo elinamaziko amaninzi ekusebenzeni ngokubanzi. I-Int J Obes edibanisa iMetab Disord 1994; 18: 99-103. Jonga i-abstract.
  200. UJefferson JW. Ukungcangcazela kweLithium kunye nokutya kwe-caffeine: iimeko ezimbini zokusela kancinci kunye nokugungqa ngakumbi. J Iklinikhi yengqondo 1988; 49: 72-3. Jonga i-abstract.
  201. UMester R, uToren P, uMizrachi I, et al. Ukurhoxiswa kweCaffeine kwonyusa amanqanaba egazi e-lithium. I-Biol Psychiatry 1995; 37: 348-50 (PubMed) (Umnqamlezo) Jonga i-abstract.
  202. IHealy DP, iPolk RE, iKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin kunye ne-caffeine kumavolontiya aqhelekileyo. Iiarhente zeAntimicrob Chemother 1989; 33: 474-8. Jonga i-abstract.
  203. UCarbo M, uSegura J, uDe la Torre R, okqhubekayo. Iziphumo zequinolones ekubekweni kwe-caffeine. KwiKlinikhi ye-Pharmacol Ther 1989; 45: 234-40. Jonga i-abstract.
  204. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T.I-Ciprofloxacin-caffeine: Unxibelelwano lweziyobisi olusekwe kusetyenziswa i-vivo kunye nophando lwe-vitro. NdinguJ Med 1989; 87: 89S-91S. Jonga i-abstract.
  205. UMcEvoy GK, ed. Ulwazi lwe-AHFS yeziyobisi. I-Bethesda, MD: Umbutho waseMelika we-Health-System Pharmacists, 1998.
  206. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ii-eds. Incwadana yokhuseleko lwezityalo yaseMelika. IBoca Raton, FL: ICR Press, LLC 1997.
  207. USchulz V, uHansel R, uTyler VE. Rational Phytotherapy: Isikhokelo sikaGqirha kwiHerbal Medicine. UTerry C. Telger, uguqulele. Ngomhla wesi-3. IBerlin, iGER: Ispringer, 1998.
Ukuhlaziywa kokugqibela-01/05/2021

Qiniseka Ukuba Ujonge

Unyango oluNcedisayo kunye noKhathalelo lweRenal Cell Carcinoma
Zempilo

Unyango oluNcedisayo kunye noKhathalelo lweRenal Cell Carcinoma

Ugqirha wakho uya kukunceda uthathe i igqibo kunyango lwe-renal cell carcinoma (RCC) e ekwe kwimpilo yakho ngokubanzi kunye nokuba umhlaza wakho u a azeke kangakanani. Unyango lwe-RCC luhlala lubandak...
Nguwuphi uMndilili weXesha loQeqesho lwaMakhwenkwe naMantombazana?
Zempilo

Nguwuphi uMndilili weXesha loQeqesho lwaMakhwenkwe naMantombazana?

Umntwana wam kufuneka aqale nini ukuqeqe ha amanzi?Ukufunda uku ebenzi a indlu yanga e e kubalulekile. Uninzi lwabantwana baqala uku ebenza kobu buchule phakathi kweenyanga ezili-18 ukuya kwiminyaka ...